These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16022112)

  • 1. [Modern programs of treatment and rehabilitation of patients with basaliomas: their pathogenic substantiation and clinical effectiveness].
    Snarskaia ES; Suchkov SV; Molochkov VA
    Vestn Ross Akad Med Nauk; 2005; (6):41-5. PubMed ID: 16022112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for nonmelanoma skin cancer: does it have a future?
    Urosevic M; Dummer R
    Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The skinny on nonmelanoma skin cancer.
    Johns Hopkins Med Lett Health After 50; 2006 Jul; 18(5):4-5. PubMed ID: 16848040
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment efficacy in skin basaliomas].
    Pisklakova TP; Il'in II
    Vestn Dermatol Venerol; 1990; (8):66-7. PubMed ID: 2256387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermatology--new therapeutic possibilities. The Danish Society of Dermatology].
    Gniadecki R; Haedersdal M
    Ugeskr Laeger; 2006 Mar; 168(12):1213. PubMed ID: 16571304
    [No Abstract]   [Full Text] [Related]  

  • 7. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
    Buechner SA
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of immunotherapy in the treatment of non-melanoma skin cancers.
    Sauder DN
    Nat Clin Pract Oncol; 2005 Jul; 2(7):326-7. PubMed ID: 16075786
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders?
    Lejeune FJ
    Melanoma Res; 2006 Oct; 16(5):377-8. PubMed ID: 17013085
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology of basal cell carcinoma (Part II).
    Miller SJ
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):161-75. PubMed ID: 2007661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant epithelial and melanocytic skin tumors].
    Guillot B; Du-Thanh A
    Rev Prat; 2012 Feb; 62(2):247-54. PubMed ID: 22408878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].
    Enk AH; Becker JC; Schuler G
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma: is immunotherapy of benefit?
    Faries MB; Morton DL
    Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
    [No Abstract]   [Full Text] [Related]  

  • 14. Basal cell carcinomas do metastasize.
    Junor EJ; Campbell I; Symonds RP
    Br J Radiol; 1992 Oct; 65(778):943-4. PubMed ID: 1422672
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination.
    Correll A; Tuettenberg A; Becker C; Jonuleit H
    Exp Dermatol; 2010 Aug; 19(8):e213-21. PubMed ID: 20500773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine and skin cancer therapy: dealing with a moving target.
    Dummer R
    Curr Opin Oncol; 2014 Mar; 26(2):182-3. PubMed ID: 24469023
    [No Abstract]   [Full Text] [Related]  

  • 17. Basal-cell carcinoma.
    Rubin AI; Chen EH; Ratner D
    N Engl J Med; 2005 Nov; 353(21):2262-9. PubMed ID: 16306523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aproaches to immunotherapy in different immunophenotypes of cutaneous basal cell carcinoma].
    Petrunin DD; Okovityĭ SV; Kostalevskaia AV; Suchkov SV
    Vopr Onkol; 2012; 58(3):406-12, 415. PubMed ID: 22888660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmelanoma skin cancer of the head and neck: nonsurgical treatment.
    Ermertcan AT; Hellings PW; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):445-54. PubMed ID: 23084297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histology-based treatment of basal cell carcinoma.
    Mosterd K; Arits AH; Thissen MR; Kelleners-Smeets NW
    Acta Derm Venereol; 2009; 89(5):454-8. PubMed ID: 19734968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.